Glucagon/T3 corrects dyslipidemia, obesity, and hyperglycemia in DIO mice
•
Glucagon/T3 improves NASH and atherosclerosis in preclinical disease models
•
Precise delivery of T3 to the liver mediates benefits and spares cardiac toxicity
•
Hepatic T3 action counteracts the diabetogenic liability of glucagon
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.